Efficacy and safety of antibiotic regimens for Helicobacter pylori eradication: a systematic review and meta-analysis
Abstract
Background Helicobacter pylori infection, a global health concern, is treated with various antibiotic regimens, but rising resistance causes variable outcomes. This meta-analysis evaluated the efficacy and safety of different eradication regimens. Methods PubMed, Embase, and Web of Science were searched from inception to October 2025. Randomized and observational studies reporting eradication rates or adverse events were included. Pooled estimates were calculated using random-effects models with subgroup analyses and meta-regression. Results Fifty-seven studies (19,941 participants, 127 arms) were included. The pooled eradication rate was 83.0% (95% CI: 81.4%–84.5%; I²=87.3%). Egger's and Begg's tests indicated publication bias (both P <0.001); trim-and-fill adjusted rate was 78.1%. Subgroup analyses showed sequential (84.3%), quadruple (83.3%), and dual therapy (83.8%) achieved slightly higher rates than triple therapy (79.2%). PCAB-based regimens outperformed PPI-based (85.3% vs. 81.6%). Ten-day regimens yielded higher rates (85.9%) than 7-day (79.8%) or 14-day (82.7%). Regimens with three antibiotics (86.9%) or nitroimidazoles (84.8%) showed improved efficacy. Meta-regression identified publication year, continent, study design, and acid suppressant as heterogeneity sources (all P <0.01). For safety (54 studies, 119 arms, 5,202 events), pooled adverse event incidence was 26.1% (95% CI: 21.0%–31.9%; I²=95.3%). Sequential therapy had the highest incidence (54.1%), dual…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 19,941 participants or records.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- Occupation and risk of severe COVID-19: prospective cohort study of 120,075 UK Biobank participants
- Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
- Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
- Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.